Bacillaene, a novel polyene antibiotic, was discovered and isolated from fermentation broths of a strain of Bacillus subtilis. The novel antibiotic has a nominal molecular weight of 580 and an empirical formula of C3 5H48O7.Bacillaene is active against a broad spectrum of bacteria in agar-plate diffusion assays. Studies in vitro indicate that the antibiotic inhibits prokaryotic protein synthesis but not eukaryotic protein synthesis. Cell survival studies performed with strains of Escherichia coli indicate that the antibiotic is a bacteriostatic agent.
In the course of screening for novel antibiotics that inhibit protein synthesis initiation, a novel polyene antibacterial agent, bacillaene, was discovered as a component of the fermentation broth of Bacillus subtilis. In addition to this novel compound, the fermentation broth contained at least two other antibiotics, namely the previously described compounds, difficidin and oxydifiicidin1~3).
Bacillaene is a hexaene, as shown by its UVabsorption spectrum. In in vitro agar diffusion assays, bacillaene inhibits both Gram-positive and Gramnegative bacteria but no inhibitory activity was found against Candida species. The activity in vitro was especially potent against hyper-permeable strains of Escherichia coli. Studies in vitro indicate that the antibiotic is bacteriostatic and that it acts at the level of protein synthesis. The activity is selective in that it inhibits prokaryotic but not eukaryotic protein synthesis.
Isolation of the Organism The bacillaene producing organism was isolated from a soil sample collected in Tokyo, Japan. Approximately 0.5g of the soil was suspended in 10ml of sterile phosphate-buffered saline containing 0.1% gelatin. Aliquots of the suspension were plated on to the surface of nutrient agar composed of the following: yeast extract 2.5g, peptone 2.0g, glucose 2.0g, beef 997 extract 5.0g, MgSO4-7H2O 0.5g, FeSO4-7H2O 0.2g, NaCl 0.1 g, agar 20.0 g and distilled water to 1 liter. After autoclaving, filter-sterilized solutions of cycloheximide and colistin were added to the mediumso that their final concentrations in the agar were lOOmgand lOmg per liter of agar, respectively. The plates were incubated for 5 days at 22°C, at which time colonies exhibiting the morphological and cultural characteristics described below were picked and sub-cultured. They were maintained on slants of mediumcomposed of the follow- Whengrown aerobically in broth culture, the growth was in the form of a dull, wrinkled pellicle at the surface of the broth. Growth was observed at 28°C and 37°C but not at 55°C.
These characteristics are in agreement with those described for Bacillus subtilis by Gordon et al.3A) and establish the identity of the organism as Bacillus subtilis.
The strain has been deposited in the American Type Culture Collection with the accession number ATCC 55422.
Fermentation
Yeast beef agar slants, whose composition was: beef extract 1.5 g, yeast extract 3.0g, peptone 6.0g, K2HPO4 3.68 g, KH2PO4 1.32g, distilled water 1 liter, were seeded with B. subtilis ATCC55422 and incubated 24 to 48 hours at 25°C. The growth was then washed off the slants and used to inoculate 100ml of germination medium of the following composition contained in 500 ml Erlenmeyer flasks: toasted nutrisoy flour 15 g, soluble starch 15g, glucose 50g, CoCl2-6H2O 0.005g, CaCO3 10g, distilled water 1liter. After 24 to 48hours incubation, 100 ml aliquots from the germination flasks were used to inoculate 1 liter of fresh germination medium in 2.8 liter Erlenmeyer flasks. The fermentation flasks were incubated 48 hours at 25°C on a rotary shaker at which time they were harvested. Isolation and Purification The isolation and purification of bacillaene from 10liters of shake flask culture was carried out as summarized in Fig. 1 stirring the mixture for thirty minutes. Centrifugation was employed to recover cells, the aqueous and the ethyl acetate layers. The recovered cells and the aqueous phase were combined and extracted in a second step with a fresh portion of 4.0 liters of ethyl acetate. Most of the bacillaene, ca. 70%to 80%of the total, was extracted in the first step, as evidenced by UV spectroscopy of concentrated extracts. The extracts were combinedand concentrated in vaccuo to yield an oily residue which was mixed with 5.0ml of methanol for application to a CHP20P column (5 x 30cm, Mitsubishi Chemical Ind. Ltd. Japan). The column was prepared and equilibrated in 10 mMphosphate buffer at pH 6.5, and after injection of the sample, a linear gradient was run employing 1.0 liter of starting buffer and 1.0 liter of methanol. At the end of the gradient the elution was continued with pure methanol. A low pressure pumpwas used to provide a solvent flow rate of 20 ml/minute. Initially, three 500 ml volumes were collected, followed by collecting fractions acteristic band pattern of a conjugated hexaene with individual bands appearing at 343, 361 and 382nm (Fig.  3) . The 13C-NMR spectrum (Bruker AM-500, 125 MHz, methanol-d6, Fig. 4 formula. The proton spectrum of bacillaene (Bruker AM-500, 500 MHz, methanol-J6) is in agreement with the above analysis and is shownin Figure 5 .
Biological Activity Anti-bacterial Activity In Vitro The anti-bacterial activity in vitro of bacillaene was determined against a wide spectrum of bacteria using agar plate diffusion assays8). Briefly, the organisms were seeded in Luria agar (Bacto-tryptone 10 g, yeast-extract 5.0g, NaCl lOg, water 1 liter) and the test compounds were loaded into 3mmwells punched in the agar. The plates were incubated at 37°C over-night and the zones of growth inhibition measured. The growth inhibition zone sizes are as shownin Table 2 . Bacillaene has no activity against Saccharomycescerevisiae or Candida The spectrum was recorded in methanol-^6, chemical shifts are given in ppm. albicans. The minimum inhibitory concentration value of bacillaene against wild type E. coli and hyper permeable strains of E. coli5'6) were determined by employing a standard two-fold tube dilution assay9).
Bacillaene is extremely potent against hyper-permeable strains of E. coli with an MIC of less than 1.0/ig/ml in all cases except against the E. coli strain SCI0857 where the MIC is 5.0jug/ml. The results of a typical MIC study is as shown in Table 3 .
Inhibition of Protein Synthesis In Vitro THE JOURNAL OF ANTIBIOTICS
To determine the biological mode of action of bacillaene, in vitro protein synthesis assays were performed in the presence of the compound. The procaryotic protein synthesis assay employed was an E. coli based transcription-translation coupled assay10), whereas, the eucaryotic protein synthesis assay was a rabbit-reticulocyte based system1 lfl2). In both systems, These strains are hyperpermeable. SEPT. 1995 the incorporation of 35S-labelled methionine into acid-insoluble material was monitored. Bacillaene was found to inhibit prokaryotic in vitro protein synthesis, however, it failed to inhibit eucaryotic protein synthesis at the concentrations tested. At a final concentration of 0.75 /ig/ml, bacillaene inhibited > 85% of incorporation of the radio-labelled amino acid into acid-insoluble material in the procaryotic protein synthesis assay as compared to the control where no inhibitor was added to the assay mix. The inhibition was 95% when the concentration of bacillaene was increased to 1.5 /xg/ml. No inhibition of the incorporation of the radio-labelled methionine into acid-insoluble material was seen at similar concentrations in the in vitro eucaryotic protein synthesis assay. The results are as shown in Table 4 .
Effect of Bacillaene on Cell Viability
To study the effect of bacillaene on cell viability, standard broth dilution assays in the presence of the drug were performed9). Briefly, the drug was added at 10 x the MICto a log phase culture ofE. coli strain BAS-847. The culture was grownaerobically in Luria broth at 37°C. At various time intervals, aliquots of the culture were withdrawn, diluted and plated on Luria agar. The plates were incubated at 37°C over-night and the number of survivors determined by counting the colonies. As is the case for manyprotein synthesis inhibitors, the growth inhibitory activity of bacillaene appears to be bacteriostatic9 Moreover, they all contain ring structures whereas bacillaene is unique in this group in that it does not. 
